| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 2.05e-30 | 114 | 51 | 19 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.14e-29 | 124 | 51 | 19 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 8.59e-29 | 137 | 51 | 19 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 7.09e-26 | 192 | 51 | 19 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 ADAMTS9 USP17L20 USP17L11 USP17L24 ADAMTS16 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 2.20e-18 | 654 | 51 | 21 | GO:0008233 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF677 ZNF16 ZNF836 WT1 PLAGL2 ZNF75CP ZNF221 ZNF615 ZNF841 ZNF226 ZNF229 ZNF442 ZNF426 CASZ1 ZFP62 ZNF284 | 2.41e-07 | 1412 | 51 | 16 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF677 ZNF16 ZNF836 WT1 ZNF75CP ZNF221 ZNF615 ZNF841 ZNF226 ZNF229 ZNF442 ZNF426 CASZ1 ZFP62 ZNF284 | 2.17e-06 | 1459 | 51 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | MAF1 ZNF677 ZNF16 ZNF836 WT1 ZNF75CP ZNF221 ZNF615 ZNF841 ZNF226 ZNF229 ZNF426 ZFP62 ZNF284 | 2.33e-06 | 1271 | 51 | 14 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF677 ZNF16 ZNF836 WT1 ZNF75CP ZNF221 ZNF615 ZNF841 ZNF226 ZNF229 ZNF426 ZFP62 ZNF284 | 1.03e-05 | 1244 | 51 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.07e-05 | 560 | 51 | 9 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.17e-05 | 566 | 51 | 9 | GO:0001216 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 4.59e-30 | 125 | 50 | 19 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 8.02e-29 | 144 | 50 | 19 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 7.66e-13 | 1009 | 50 | 19 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 2.30e-12 | 1074 | 50 | 19 | GO:0043687 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.17e-10 | 1293 | 51 | 18 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.64e-10 | 1299 | 51 | 18 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 9.35e-10 | 1327 | 51 | 18 | GO:0042175 |
| HumanPheno | Small hand | 1.29e-04 | 122 | 5 | 3 | HP:0200055 | |
| HumanPheno | Persistence of primary teeth | 2.68e-04 | 27 | 5 | 2 | HP:0006335 | |
| HumanPheno | Abnormal female external genitalia morphology | 2.96e-04 | 161 | 5 | 3 | HP:0000055 | |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | 3.01e-04 | 1008 | 5 | 5 | HP:0009122 | |
| HumanPheno | Wide nasal bridge | 4.51e-04 | 508 | 5 | 4 | HP:0000431 | |
| HumanPheno | Scoliosis | 5.15e-04 | 1122 | 5 | 5 | HP:0002650 | |
| HumanPheno | Abnormal blood vessel morphology | 7.24e-04 | 1201 | 5 | 5 | HP:0033353 | |
| HumanPheno | Clinodactyly | 7.27e-04 | 574 | 5 | 4 | HP:0030084 | |
| HumanPheno | Abnormal curvature of the vertebral column | 7.80e-04 | 1219 | 5 | 5 | HP:0010674 | |
| HumanPheno | Abnormal lip morphology | 8.81e-04 | 1249 | 5 | 5 | HP:0000159 | |
| HumanPheno | Abnormal renal morphology | 8.91e-04 | 1252 | 5 | 5 | HP:0012210 | |
| HumanPheno | Abnormal calvaria morphology | 8.99e-04 | 1254 | 5 | 5 | HP:0002683 | |
| HumanPheno | Epicanthus | 9.46e-04 | 614 | 5 | 4 | HP:0000286 | |
| HumanPheno | Flexion contracture of finger | 9.63e-04 | 240 | 5 | 3 | HP:0005651 | |
| HumanPheno | Camptodactyly (hands) | 9.63e-04 | 240 | 5 | 3 | HP:0010563 | |
| HumanPheno | Camptodactyly of toe | 9.63e-04 | 240 | 5 | 3 | HP:0001836 | |
| HumanPheno | Joint contractures involving the joints of the feet | 9.63e-04 | 240 | 5 | 3 | HP:0100492 | |
| HumanPheno | Camptodactyly of finger | 9.63e-04 | 240 | 5 | 3 | HP:0100490 | |
| HumanPheno | Flexion contracture of toe | 9.63e-04 | 240 | 5 | 3 | HP:0005830 | |
| HumanPheno | Interphalangeal joint contracture of finger | 9.63e-04 | 240 | 5 | 3 | HP:0001220 | |
| HumanPheno | Toe joint contracture | 9.74e-04 | 241 | 5 | 3 | HP:0034675 | |
| HumanPheno | Hypoplasia of the middle phalanges of the hand | 1.12e-03 | 55 | 5 | 2 | HP:0010240 | |
| HumanPheno | Short middle phalanx of finger | 1.12e-03 | 55 | 5 | 2 | HP:0005819 | |
| HumanPheno | Abnormal vascular morphology | 1.16e-03 | 1319 | 5 | 5 | HP:0025015 | |
| HumanPheno | Flexion contracture of finger | 1.18e-03 | 257 | 5 | 3 | HP:0012785 | |
| HumanPheno | Abnormal thorax morphology | 1.20e-03 | 1328 | 5 | 5 | HP:0000765 | |
| HumanPheno | Finger joint contracture | 1.20e-03 | 259 | 5 | 3 | HP:0034681 | |
| HumanPheno | Abnormal phalangeal joint morphology of the hand | 1.25e-03 | 262 | 5 | 3 | HP:0006261 | |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | 1.27e-03 | 1343 | 5 | 5 | HP:0009115 | |
| HumanPheno | Aplasia/Hypoplasia of the middle phalanges of the hand | 1.42e-03 | 62 | 5 | 2 | HP:0009843 | |
| HumanPheno | Short 5th finger | 1.52e-03 | 64 | 5 | 2 | HP:0009237 | |
| HumanPheno | Oligodontia | 1.56e-03 | 65 | 5 | 2 | HP:0000677 | |
| HumanPheno | Short stature | 1.60e-03 | 1407 | 5 | 5 | HP:0004322 | |
| HumanPheno | Abnormal eyelid morphology | 1.61e-03 | 1408 | 5 | 5 | HP:0000492 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 1.61e-03 | 66 | 5 | 2 | HP:0006262 | |
| HumanPheno | Rhizomelia | 1.66e-03 | 67 | 5 | 2 | HP:0008905 | |
| HumanPheno | Rhizomelic shortening | 1.66e-03 | 67 | 5 | 2 | HP:0002968 | |
| HumanPheno | Joint contractures | 1.71e-03 | 292 | 5 | 3 | HP:0001372 | |
| HumanPheno | Renal duplication | 1.76e-03 | 69 | 5 | 2 | HP:0000075 | |
| HumanPheno | Abdominal organ duplication | 1.76e-03 | 69 | 5 | 2 | HP:0005217 | |
| HumanPheno | Joint contracture of the hand | 1.78e-03 | 296 | 5 | 3 | HP:0009473 | |
| HumanPheno | Abnormal size of the palpebral fissures | 1.81e-03 | 298 | 5 | 3 | HP:0200007 | |
| HumanPheno | Aplasia/Hypoplasia involving bones of the feet | 1.81e-03 | 298 | 5 | 3 | HP:0006494 | |
| HumanPheno | Abnormal renal pelvis morphology | 1.85e-03 | 300 | 5 | 3 | HP:0010944 | |
| HumanPheno | Long palpebral fissure | 1.86e-03 | 71 | 5 | 2 | HP:0000637 | |
| HumanPheno | Frontal bossing | 1.94e-03 | 738 | 5 | 4 | HP:0002007 | |
| HumanPheno | Abnormal shape of the frontal region | 1.97e-03 | 741 | 5 | 4 | HP:0011218 | |
| HumanPheno | Abnormal middle phalanx morphology of the hand | 1.97e-03 | 73 | 5 | 2 | HP:0009833 | |
| HumanPheno | Abnormal frontal bone morphology | 1.98e-03 | 742 | 5 | 4 | HP:0430000 | |
| HumanPheno | Asymmetric growth | 2.08e-03 | 75 | 5 | 2 | HP:0100555 | |
| HumanPheno | Aplasia involving bones of the extremities | 2.16e-03 | 759 | 5 | 4 | HP:0009825 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the extremities | 2.18e-03 | 761 | 5 | 4 | HP:0045060 | |
| HumanPheno | Cryptorchidism | 2.40e-03 | 780 | 5 | 4 | HP:0000028 | |
| HumanPheno | Abnormality of primary teeth | 2.48e-03 | 82 | 5 | 2 | HP:0006481 | |
| HumanPheno | Foot joint contracture | 2.53e-03 | 334 | 5 | 3 | HP:0008366 | |
| HumanPheno | Thin upper lip vermilion | 2.64e-03 | 339 | 5 | 3 | HP:0000219 | |
| HumanPheno | Thin lips | 2.64e-03 | 339 | 5 | 3 | HP:0000213 | |
| HumanPheno | Camptodactyly | 2.80e-03 | 346 | 5 | 3 | HP:0012385 | |
| HumanPheno | Aplasia/hypoplasia of the extremities | 2.81e-03 | 813 | 5 | 4 | HP:0009815 | |
| HumanPheno | Abnormal labia morphology | 2.85e-03 | 88 | 5 | 2 | HP:0000058 | |
| HumanPheno | Generalized hirsutism | 2.92e-03 | 89 | 5 | 2 | HP:0002230 | |
| HumanPheno | Delayed skeletal maturation | 2.95e-03 | 352 | 5 | 3 | HP:0002750 | |
| HumanPheno | 2-3 toe syndactyly | 2.98e-03 | 90 | 5 | 2 | HP:0004691 | |
| HumanPheno | Upper-limb joint contracture | 3.20e-03 | 362 | 5 | 3 | HP:0100360 | |
| HumanPheno | Flexion contracture of digit | 3.20e-03 | 362 | 5 | 3 | HP:0030044 | |
| HumanPheno | Tooth agenesis | 3.22e-03 | 363 | 5 | 3 | HP:0009804 | |
| HumanPheno | Micrognathia | 3.24e-03 | 843 | 5 | 4 | HP:0000347 | |
| HumanPheno | Aplasia/Hypoplasia of the mandible | 3.27e-03 | 845 | 5 | 4 | HP:0009118 | |
| HumanPheno | Abnormal circulating hormone concentration | 3.42e-03 | 855 | 5 | 4 | HP:0003117 | |
| HumanPheno | Abnormal lower limb bone morphology | 3.59e-03 | 866 | 5 | 4 | HP:0040069 | |
| HumanPheno | Hypospadias | 3.59e-03 | 377 | 5 | 3 | HP:0000047 | |
| HumanPheno | Wide anterior fontanel | 3.60e-03 | 99 | 5 | 2 | HP:0000260 | |
| HumanPheno | Abnormal clitoris morphology | 3.67e-03 | 100 | 5 | 2 | HP:0000056 | |
| HumanPheno | Patent ductus arteriosus | 3.73e-03 | 382 | 5 | 3 | HP:0001643 | |
| HumanPheno | Abnormal hair quantity | 3.95e-03 | 888 | 5 | 4 | HP:0011362 | |
| MousePheno | increased trophectoderm apoptosis | 2.17e-07 | 8 | 23 | 3 | MP:0012119 | |
| MousePheno | increased thymus weight | 7.70e-06 | 24 | 23 | 3 | MP:0004955 | |
| MousePheno | skin edema | 8.64e-05 | 53 | 23 | 3 | MP:0001786 | |
| MousePheno | increased embryonic tissue cell apoptosis | 1.04e-04 | 153 | 23 | 4 | MP:0013504 | |
| MousePheno | abnormal thymus weight | 1.25e-04 | 60 | 23 | 3 | MP:0004954 | |
| MousePheno | decreased regulatory T cell number | 1.52e-04 | 64 | 23 | 3 | MP:0004974 | |
| MousePheno | abnormal embryonic tissue cell apoptosis | 1.94e-04 | 180 | 23 | 4 | MP:0013503 | |
| MousePheno | abnormal mesenchyme morphology | 2.94e-04 | 80 | 23 | 3 | MP:0006301 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 3.08e-04 | 203 | 23 | 4 | MP:0011094 | |
| MousePheno | abnormal skin condition | 4.70e-04 | 227 | 23 | 4 | MP:0001191 | |
| MousePheno | abnormal reproductive system development | 5.51e-04 | 99 | 23 | 3 | MP:0003936 | |
| MousePheno | embryonic lethality before implantation | 5.99e-04 | 242 | 23 | 4 | MP:0006204 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 6.91e-04 | 107 | 23 | 3 | MP:0003694 | |
| MousePheno | abnormal blastocyst hatching | 8.10e-04 | 113 | 23 | 3 | MP:0003693 | |
| MousePheno | abnormal regulatory T cell number | 8.52e-04 | 115 | 23 | 3 | MP:0004972 | |
| MousePheno | primary atelectasis | 8.86e-04 | 27 | 23 | 2 | MP:0010819 | |
| MousePheno | abnormal regulatory T cell morphology | 8.96e-04 | 117 | 23 | 3 | MP:0004941 | |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L2 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 8.04e-36 | 16 | 48 | 14 | IPR006861 |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L2 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 8.04e-36 | 16 | 48 | 14 | PF04774 |
| Domain | UCH | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L8 USP17L13 USP17L18 | 1.77e-32 | 71 | 48 | 18 | PF00443 |
| Domain | USP_2 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L8 USP17L13 USP17L18 | 1.77e-32 | 71 | 48 | 18 | PS00973 |
| Domain | USP_dom | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L8 USP17L13 USP17L18 | 2.35e-32 | 72 | 48 | 18 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L8 USP17L13 USP17L18 | 2.35e-32 | 72 | 48 | 18 | IPR001394 |
| Domain | USP_3 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L8 USP17L13 USP17L18 | 2.35e-32 | 72 | 48 | 18 | PS50235 |
| Domain | USP_CS | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L8 USP17L13 USP17L18 | 8.65e-31 | 66 | 48 | 17 | IPR018200 |
| Domain | USP_1 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L8 USP17L13 USP17L18 | 2.69e-30 | 70 | 48 | 17 | PS00972 |
| Domain | zf-C2H2 | ZNF677 ZNF16 ZNF836 WT1 PLAGL2 ZNF221 ZNF615 ZNF841 ZNF226 ZNF229 ZNF442 ZNF426 CASZ1 ZFP62 ZNF284 | 1.05e-10 | 693 | 48 | 15 | PF00096 |
| Domain | zf-C2H2_6 | ZNF677 ZNF16 ZNF836 PLAGL2 ZNF615 ZNF841 ZNF229 ZNF442 ZNF426 ZFP62 ZNF284 | 3.31e-10 | 314 | 48 | 11 | PF13912 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF677 ZNF16 ZNF836 WT1 PLAGL2 ZNF221 ZNF615 ZNF841 ZNF226 ZNF229 ZNF442 ZNF426 CASZ1 ZFP62 ZNF284 | 4.95e-10 | 775 | 48 | 15 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF677 ZNF16 ZNF836 WT1 PLAGL2 ZNF221 ZNF615 ZNF841 ZNF226 ZNF229 ZNF442 ZNF426 CASZ1 ZFP62 ZNF284 | 5.13e-10 | 777 | 48 | 15 | PS00028 |
| Domain | Znf_C2H2-like | ZNF677 ZNF16 ZNF836 WT1 PLAGL2 ZNF221 ZNF615 ZNF841 ZNF226 ZNF229 ZNF442 ZNF426 CASZ1 ZFP62 ZNF284 | 7.16e-10 | 796 | 48 | 15 | IPR015880 |
| Domain | Znf_C2H2 | ZNF677 ZNF16 ZNF836 WT1 PLAGL2 ZNF221 ZNF615 ZNF841 ZNF226 ZNF229 ZNF442 ZNF426 CASZ1 ZFP62 ZNF284 | 8.36e-10 | 805 | 48 | 15 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF677 ZNF16 ZNF836 WT1 PLAGL2 ZNF221 ZNF615 ZNF841 ZNF226 ZNF229 ZNF442 ZNF426 CASZ1 ZFP62 ZNF284 | 8.80e-10 | 808 | 48 | 15 | SM00355 |
| Domain | - | ZNF677 ZNF16 ZNF836 WT1 PLAGL2 ZNF221 ZNF615 ZNF841 ZNF226 ZNF229 ZNF442 ZNF426 ZFP62 ZNF284 | 9.47e-10 | 679 | 48 | 14 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF677 ZNF16 ZNF836 WT1 PLAGL2 ZNF221 ZNF615 ZNF841 ZNF226 ZNF229 ZNF442 ZNF426 ZFP62 ZNF284 | 1.26e-09 | 694 | 48 | 14 | IPR013087 |
| Domain | KRAB | ZNF677 ZNF836 ZNF221 ZNF615 ZNF226 ZNF229 ZNF442 ZNF426 ZNF284 | 2.74e-07 | 358 | 48 | 9 | PS50805 |
| Domain | KRAB | ZNF677 ZNF836 ZNF221 ZNF615 ZNF226 ZNF229 ZNF442 ZNF426 ZNF284 | 2.74e-07 | 358 | 48 | 9 | PF01352 |
| Domain | KRAB | ZNF677 ZNF836 ZNF221 ZNF615 ZNF226 ZNF229 ZNF442 ZNF426 ZNF284 | 3.54e-07 | 369 | 48 | 9 | SM00349 |
| Domain | KRAB | ZNF677 ZNF836 ZNF221 ZNF615 ZNF226 ZNF229 ZNF442 ZNF426 ZNF284 | 3.62e-07 | 370 | 48 | 9 | IPR001909 |
| Domain | ADAM_spacer1 | 1.58e-03 | 23 | 48 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.58e-03 | 23 | 48 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.72e-03 | 24 | 48 | 2 | IPR013273 | |
| Domain | Pep_M12B_propep | 4.51e-03 | 39 | 48 | 2 | PF01562 | |
| Domain | Peptidase_M12B_N | 4.51e-03 | 39 | 48 | 2 | IPR002870 | |
| Domain | DISINTEGRIN_1 | 4.74e-03 | 40 | 48 | 2 | PS00427 | |
| Domain | Reprolysin | 4.74e-03 | 40 | 48 | 2 | PF01421 | |
| Domain | ADAM_MEPRO | 4.74e-03 | 40 | 48 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 4.74e-03 | 40 | 48 | 2 | PS50214 | |
| Domain | Peptidase_M12B | 4.74e-03 | 40 | 48 | 2 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 4.98e-03 | 41 | 48 | 2 | PS00546 | |
| Domain | Disintegrin_dom | 4.98e-03 | 41 | 48 | 2 | IPR001762 | |
| Domain | Pept_M10_metallopeptidase | 5.46e-03 | 43 | 48 | 2 | IPR001818 | |
| Domain | TSP_1 | 1.14e-02 | 63 | 48 | 2 | PF00090 | |
| Domain | TSP1_rpt | 1.21e-02 | 65 | 48 | 2 | IPR000884 | |
| Domain | TSP1 | 1.21e-02 | 65 | 48 | 2 | PS50092 | |
| Domain | TSP1 | 1.21e-02 | 65 | 48 | 2 | SM00209 | |
| Domain | - | 1.84e-02 | 81 | 48 | 2 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 1.84e-02 | 81 | 48 | 2 | IPR024079 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.38e-36 | 45 | 39 | 18 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.11e-24 | 191 | 39 | 18 | MM15289 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 7.59e-23 | 221 | 39 | 18 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.72e-21 | 262 | 39 | 18 | MM15286 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.89e-20 | 299 | 39 | 18 | M27574 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.76e-20 | 318 | 39 | 18 | MM15278 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 ADAMTS9 USP17L20 USP17L11 ADAMTS16 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 7.17e-11 | 1389 | 39 | 20 | MM15307 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 ADAMTS9 USP17L20 USP17L11 USP17L24 ADAMTS16 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 2.13e-10 | 1475 | 39 | 20 | M19806 |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 4.29e-50 | 21 | 51 | 18 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 4.29e-50 | 21 | 51 | 18 | 8756639 |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 4.29e-50 | 21 | 51 | 18 | 8622927 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 4.29e-50 | 21 | 51 | 18 | 14583620 | |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 4.29e-50 | 21 | 51 | 18 | 12447969 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 4.29e-50 | 21 | 51 | 18 | 18980247 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 2.36e-49 | 22 | 51 | 18 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 4.33e-48 | 24 | 51 | 18 | 8995226 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.55e-47 | 25 | 51 | 18 | 21115691 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 2.49e-47 | 33 | 51 | 19 | 20228807 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.02e-47 | 26 | 51 | 18 | 35816173 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.63e-47 | 34 | 51 | 19 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.63e-47 | 34 | 51 | 19 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.63e-47 | 34 | 51 | 19 | 20368735 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.63e-47 | 34 | 51 | 19 | 15780755 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.63e-47 | 34 | 51 | 19 | 20403174 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.63e-47 | 34 | 51 | 19 | 19188362 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.63e-47 | 34 | 51 | 19 | 17109758 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.63e-47 | 34 | 51 | 19 | 11941478 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.63e-47 | 34 | 51 | 19 | 20388806 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.63e-47 | 34 | 51 | 19 | 14699124 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.63e-47 | 34 | 51 | 19 | 10936051 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.63e-47 | 34 | 51 | 19 | 21448158 | |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.23e-46 | 35 | 51 | 19 | 21239494 |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.23e-46 | 35 | 51 | 19 | 16611142 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 2.60e-46 | 36 | 51 | 19 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.35e-46 | 37 | 51 | 19 | 20228808 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.11e-45 | 29 | 51 | 18 | 32527007 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.68e-40 | 50 | 51 | 18 | 31806660 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 XAF1 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.09e-20 | 674 | 51 | 19 | 37196079 | |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 1.13e-18 | 10 | 51 | 7 | 24207026 | |
| Pubmed | 7.47e-18 | 12 | 51 | 7 | 24695638 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 3.23e-17 | 14 | 51 | 7 | 11793228 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 4.72e-16 | 19 | 51 | 7 | 28067227 | |
| Pubmed | 3.04e-11 | 81 | 51 | 7 | 12838346 | ||
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L19 USP17L18 | 4.69e-10 | 119 | 51 | 7 | 28625976 |
| Pubmed | 9.05e-09 | 48 | 51 | 5 | 16421571 | ||
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | 1.19e-08 | 4 | 51 | 3 | 22984479 | |
| Pubmed | 1.95e-08 | 20 | 51 | 4 | 12743021 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 23661704 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 16507336 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 22562232 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 18559874 | ||
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 21663736 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 39009564 | ||
| Pubmed | 1.63e-04 | 13 | 51 | 2 | 17848411 | ||
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 25145929 | ||
| Pubmed | Platelets play an essential role in murine lung development through Clec-2/podoplanin interaction. | 2.19e-04 | 15 | 51 | 2 | 29853539 | |
| Pubmed | 2.50e-04 | 16 | 51 | 2 | 30579834 | ||
| Pubmed | 3.18e-04 | 18 | 51 | 2 | 14628042 | ||
| Pubmed | ROBO2 restricts the nephrogenic field and regulates Wolffian duct-nephrogenic cord separation. | 3.55e-04 | 19 | 51 | 2 | 26116176 | |
| Pubmed | Chromosomal localization of the genes for five zinc finger proteins expressed in mouse lens. | 4.78e-04 | 22 | 51 | 2 | 7590745 | |
| Pubmed | Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. | 8.35e-04 | 29 | 51 | 2 | 22956684 | |
| Pubmed | Large-scale identification of mammalian proteins localized to nuclear sub-compartments. | 1.43e-03 | 38 | 51 | 2 | 11555636 | |
| Interaction | FLT3 interactions | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 KMT2A USP17L19 USP17L18 | 5.45e-07 | 318 | 46 | 8 | int:FLT3 |
| Interaction | USP17L7 interactions | 7.60e-05 | 6 | 46 | 2 | int:USP17L7 | |
| Cytoband | 4p16.1 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.85e-25 | 79 | 51 | 13 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.24e-19 | 222 | 51 | 13 | chr4p16 |
| Cytoband | 8p23.1 | 2.05e-08 | 154 | 51 | 6 | 8p23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 2.44e-07 | 234 | 51 | 6 | chr8p23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 4.77e-05 | 1192 | 51 | 8 | chr19q13 | |
| Cytoband | 19q13.41 | 9.26e-05 | 78 | 51 | 3 | 19q13.41 | |
| Cytoband | 19q13.31 | 4.82e-04 | 29 | 51 | 2 | 19q13.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p14 | 1.07e-02 | 140 | 51 | 2 | chr3p14 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF677 ZNF16 ZNF836 WT1 PLAGL2 ZNF221 ZNF615 ZNF841 ZNF226 ZNF229 ZNF442 ZNF426 CASZ1 ZFP62 ZNF284 | 1.89e-15 | 718 | 25 | 15 | 28 |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.09e-04 | 19 | 25 | 2 | 50 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 3.08e-33 | 86 | 49 | 18 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 PLAGL2 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 3.27e-33 | 112 | 49 | 19 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.08e-28 | 160 | 49 | 18 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.19e-17 | 647 | 49 | 18 | MM981 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 ZNF426 USP17L15 USP17L8 USP17L13 USP17L18 | 2.11e-14 | 1072 | 49 | 19 | MM1031 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 ZNF426 USP17L15 USP17L8 USP17L13 USP17L18 | 2.32e-13 | 1226 | 49 | 19 | MM979 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 2.01e-12 | 1198 | 49 | 18 | MM1062 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500 | 3.84e-05 | 45 | 31 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.69e-05 | 138 | 31 | 4 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.77e-42 | 46 | 50 | 19 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 KMT2A USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.08e-41 | 69 | 50 | 20 | DOID:1682 (implicated_via_orthology) |
| Disease | Hernia | 3.40e-03 | 51 | 50 | 2 | HP_0100790 | |
| Disease | leukemia | 3.95e-03 | 55 | 50 | 2 | C0023418 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKSTHYHCMQVGCNK | 546 | Q86V15 | |
| GKMCYVQKQPAPHSH | 141 | A6NLC5 | |
| PQHGMCSHKFYGKQC | 1201 | Q8TE57 | |
| QRYMEKSGKCNVHHG | 51 | P48544 | |
| KHMFKQFCQEGQPHV | 41 | Q9H063 | |
| SVNNFVSHQKKPYCH | 41 | Q86VF7 | |
| YKNTPENLHEMAKHN | 246 | Q53H82 | |
| APPKSCQHNGTMYQH | 106 | Q6WN34 | |
| PGNKEHHKDNNYVSM | 421 | Q9BWT3 | |
| HKQRNVYCMAKDGSH | 1461 | Q9P2N4 | |
| HPSQDGKRQYKMICH | 576 | Q02410 | |
| SVGHKNEPKMDNCHS | 2771 | Q03164 | |
| THSAQKPHQCMYCDK | 91 | Q9UPG8 | |
| HRNGKYDMSPIHQDK | 276 | Q8TBZ0 | |
| GNMNCAYFHNGKMHP | 191 | Q9P126 | |
| NIHQKTHMGGKPYTC | 276 | Q8N8J6 | |
| YKCGMKNHHPEQQSS | 471 | A6NCW0 | |
| YKCGMKNHHPEQQSS | 471 | A6NCW7 | |
| HGHNIGKKMSCQQFI | 421 | Q9BQI7 | |
| NKHFMTHQGINPYRC | 336 | Q92670 | |
| CNQMIPENKYFHHMG | 156 | Q6GPH4 | |
| YKCGMKNHHPEQQSS | 471 | D6R9N7 | |
| YKCGMKNHHPEQQSS | 471 | A8MUK1 | |
| QMHSRKHTGEKPYQC | 341 | P19544 | |
| YKCGMKNHHPEQQSS | 471 | D6R901 | |
| YKCGMKNHHPEQQSS | 471 | C9JLJ4 | |
| YKCGMKNHHPEQQSS | 471 | D6RCP7 | |
| SQGQKKLCHLYQDHM | 76 | P41221 | |
| YKCGMKNHHPEQQSS | 471 | Q7RTZ2 | |
| HMGQHLYKCNVCGKS | 511 | Q9UJW7 | |
| SHQRMHTGEKPYKCN | 336 | Q86XU0 | |
| HNSMIHTGQKSYQCN | 241 | Q9NYT6 | |
| HQRMHTGEKPYKCNV | 471 | Q6ZN19 | |
| YKCGMKNHHPEQQSS | 471 | C9JPN9 | |
| KPHTHKQCGTAFNYH | 151 | Q9H7R0 | |
| FCKHQMVHTGEKPYN | 381 | Q9UK13 | |
| YKCGMKNHHPEQQSS | 471 | Q0WX57 | |
| INHKSVHQGKQPYNC | 801 | Q8NB50 | |
| HQKSHMSEKPYECNE | 311 | P17020 | |
| YKCGMKNHHPEQQSS | 471 | P0C7H9 | |
| YKCGMKNHHPEQQSS | 471 | P0C7I0 | |
| YKCGMKNHHPEQQSS | 471 | D6RA61 | |
| YKCGMKNHHPEQQSS | 471 | C9J2P7 | |
| YKCGMKNHHPEQQSS | 471 | D6RBQ6 | |
| NNHMRTHSAQKPYTC | 436 | Q9BUY5 | |
| YKCGMKNHHPEQQSS | 471 | Q6R6M4 | |
| YKCGMKNHHPEQQSS | 471 | D6RJB6 | |
| HQMVHTTEKPYKCNE | 236 | Q6ZNA1 | |
| CLNKHQMIHSGEKPY | 876 | Q6ZNA1 | |
| HQMDHTGDKPYNCNV | 361 | Q2VY69 | |
| YKCRMKNHHPEQQSS | 471 | C9JJH3 | |
| YKCGMKNHHPEQQSS | 471 | C9JVI0 |